Pfizer Retirement and nonpension postretirement benefit obligations decreased by 2.8% to $1.98B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests rising long-term benefit obligations or lower plan asset performance, while a decrease indicates reduced future liability or improved funding status.
This represents the long-term financial obligations a company expects to pay to retired employees for pension benefits a...
Standard across capital-intensive industries with legacy workforces; peers often disclose this as part of net periodic benefit cost.
non_current_liabilities_pension_and_other_postretirement_0d4947| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $2.04B | $1.98B |
| QoQ Change | — | -2.8% |